Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Neuroinflammation"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review Article
Article image
Multiple System Atrophy: Advances in Diagnosis and Therapy
Hirohisa Watanabe, Sayuri Shima, Yasuaki Mizutani, Akihiro Ueda, Mizuki Ito
J Mov Disord. 2023;16(1):13-21.   Published online December 20, 2022
DOI: https://doi.org/10.14802/jmd.22082
  • 18,695 View
  • 797 Download
  • 13 Web of Science
  • 14 Crossref
AbstractAbstract PDF
This review summarizes improvements in understanding the pathophysiology and early clinical symptoms of multiple system atrophy (MSA) and advancements in diagnostic methods and disease-modifying therapies for the condition. In 2022, the Movement Disorder Society proposed new diagnostic criteria to develop disease-modifying therapies and promote clinical trials of MSA since the second consensus was proposed in 2008. Regarding pathogenesis, cutting-edge findings have accumulated on the interactions of α-synuclein, neuroinflammation, and oligodendroglia with neurons. In neuroimaging, introducing artificial intelligence, machine learning, and deep learning has notably improved diagnostic accuracy and individual analyses. Advancements in treatment have also been achieved, including immunotherapy therapy against α-synuclein and serotonin-targeted and mesenchymal stem cell therapies, which are thought to affect several aspects of the disease, including neuroinflammation. The accelerated progress in clarifying the pathogenesis of MSA over the past few years and the development of diagnostic techniques for detecting early-stage MSA are expected to facilitate the development of disease-modifying therapies for one of the most intractable neurodegenerative diseases.

Citations

Citations to this article as recorded by  
  • A review of treatment methods for movement disorders
    Mahdi Khezri, Shakiba Afsar
    Behavioural Brain Research.2026; 500: 115979.     CrossRef
  • Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy
    Nimisha Pradeep George, Minjun Kwon, Yong Eun Jang, Seok Gi Kim, Ji Su Hwang, Sang Seop Lee, Gwang Lee
    Cells.2025; 14(4): 265.     CrossRef
  • Characteristics of cerebral glucose metabolism in patients with cognitive impairment in multiple system atrophy
    Bin Chen, Lingchao Li, Lin Bai, Min Zhao, Ying Chang, Shi Gao
    Frontiers in Aging Neuroscience.2025;[Epub]     CrossRef
  • Comparing a BCI communication system in a patient with Multiple System Atrophy, with an animal model
    Brian Premchand, Kyaw Kyar Toe, Chuanchu Wang, Kai Rui Wan, Thevapriya Selvaratnam, Valerie Ethans Toh, Wai Hoe Ng, Camilo Libedinsky, Weiguo Chen, Ruiqi Lim, Ming-Yuan Cheng, Yuan Gao, Kai Keng Ang, Rosa Qi Yue So
    Brain Research Bulletin.2025; 223: 111289.     CrossRef
  • Trajectories of Pontine Volume in Patients with Multiple System Atrophy
    Kazuya Kawabata, Florian Krismer, Mizuki Ito, Kazuhiro Hara, Epifanio Bagarinao, Vincent Beliveau, Patrice Péran, Germain Arribarat, Anne Pavy‐Le Traon, Wassilios G. Meissner, Alexandra Foubert‐Samier, Margherita Fabbri, Mark Forrest Gordon, Aya Ogura, Ma
    Movement Disorders.2025; 40(7): 1369.     CrossRef
  • Multiple System Atrophy (Cerebellar Type) With Overlapping Progressive Muscular Atrophy Features and Genetic Erb-B2 Receptor Tyrosine Kinase 4 (ERBB4) Amyotrophic Lateral Sclerosis Variant: A Case Report
    Enrique Lorenzo C Panganiban, Raymond L Rosales
    Cureus.2025;[Epub]     CrossRef
  • Robotic Anterior Resection in a Patient with Multiple System Atrophy
    Pranali Suresh Divekar, Shalini Saksena
    Journal of Onco-Anaesthesiology and Perioperative Medicine.2025; 2(2): 102.     CrossRef
  • Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation
    Toshiki Maeda, Yasuaki Mizutani, Reiko Ohdake, Ryunosuke Nagao, Kazuya Kawabata, Sayuri Shima, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe
    Journal of Neural Transmission.2025;[Epub]     CrossRef
  • Neurodegeneration as Ecosystem Failure: A New Paradigm for Prevention and Treatment
    Gordana Velikic, Gordana Supic, Dusica L. Maric, Miljan Puletic, Maja Ovcak Kos, Danilo Vojvodic, Dusan M. Maric
    International Journal of Molecular Sciences.2025; 26(22): 11207.     CrossRef
  • A Blinded Evaluation of Brain Morphometry for Differential Diagnosis of Atypical Parkinsonism
    Kazuya Kawabata, Florian Krismer, Beatrice Heim, Anna Hussl, Christoph Mueller, Christoph Scherfler, Elke R. Gizewski, Klaus Seppi, Werner Poewe
    Movement Disorders Clinical Practice.2024; 11(4): 381.     CrossRef
  • The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy
    Toufik Abdul‐Rahman, Ranferi Eduardo Herrera‐Calderón, Arjun Ahluwalia, Andrew Awuah Wireko, Tomas Ferreira, Joecelyn Kirani Tan, Maximillian Wolfson, Shankhaneel Ghosh, Viktoriia Horbas, Vandana Garg, Asma Perveen, Marios Papadakis, Ghulam Md Ashraf, Ath
    CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
  • Delivering the diagnosis of multiple system atrophy: a multicenter survey on Japanese neurologists’ perspectives
    Miki Yoshitake, Atsuhiko Sugiyama, Takayoshi Shimohata, Nobuyuki Araki, Masahide Suzuki, Kazumoto Shibuya, Kengo Nagashima, Nobutaka Hattori, Satoshi Kuwabara
    BMC Neurology.2024;[Epub]     CrossRef
  • Clinical comparison of the 2008 and 2022 diagnostic criteria for early multiple system atrophy-cerebellar type
    Seoyeon Kim, Kyung Ah Woo, Jung Hwan Shin, Han-Joon Kim, Beomseok Jeon
    Clinical Autonomic Research.2024; 34(6): 609.     CrossRef
  • Ocular Vestibular-Evoked Myogenic Potential Assists in the Differentiation of Multiple System Atrophy From Parkinson’s Disease
    Keun-Tae Kim, Kyoungwon Baik, Sun-Uk Lee, Euyhyun Park, Chan-Nyoung Lee, Tonghoon Woo, Yukang Kim, Seoui Kwag, Hyunsoh Park, Ji-Soo Kim
    Journal of Movement Disorders.2024; 17(4): 398.     CrossRef
Original Article
Association of AXIN1 With Parkinson’s Disease in a Taiwanese Population
Hwa-Shin Fang, Chih-Ying Chao, Chun-Chieh Wang, Wen-Lang Fan, Po-Jung Huang, Hon-Chung Fung, Yih-Ru Wu
J Mov Disord. 2022;15(1):33-37.   Published online November 17, 2021
DOI: https://doi.org/10.14802/jmd.21073
  • 7,620 View
  • 285 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
Objective
A meta-analysis of locus-based genome-wide association studies recently identified a relationship between AXIN1 and Parkinson’s disease (PD). Few studies of Asian populations, however, have reported such a genetic association. The influences of rs13337493, rs758033, and rs2361988, three PD-associated genetic variants of AXIN1, were investigated in the present study because AXIN1 is related to Wnt/β-catenin signaling.
Methods
A total of 2,418 individuals were enrolled in our Taiwanese cohort for analysis of the genotypic and allelic frequency. Polymerase chain reaction–restriction fragment length polymorphism analysis was employed for rs13337493 genotyping, and the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) was used for rs758033 and rs2361988 genotyping in 672 patients with PD and 392 controls. Taiwan Biobank data of another 1,354 healthy controls were subjected to whole-genome sequencing performed using Illumina platforms at approximately 30× average depth.
Results
Our results revealed that rs758033 {odds ratios [OR] (95% confidence interval [CI]) = 0.267 [0.064, 0.795], p = 0.014} was associated with the risk of PD, and there was a trend toward a protective effect of rs2361988 (OR [95% CI] = 0.296 [0.071, 0.884], p = 0.026) under the recessive model. The TT genotype of rs758033 (OR [95% CI] = 0.271 [0.065, 0.805], p = 0.015) and the CC genotype of rs2361988 (OR [95% CI] = 0.305 [0.073, 0.913], p = 0.031) were less common in the PD group than in the non-PD group.
Conclusion
Our findings indicate that the rs758033 and rs2361988 polymorphisms of AXIN1 may affect the risk of PD in the Taiwanese population.

Citations

Citations to this article as recorded by  
  • AXIN1 Polymorphisms Potentially Modulate Parkinson’s Disease Susceptibility: A Cross-Sectional Study in Northern Han Chinese and White Populations
    Zhen Kong, Ran Yu, Chengqian Li, Qiqing He, Yuting Zhou, Xue Zhang, Yaqing Li, Anmu Xie, Binghui Hou
    Neurology and Therapy.2026; 15(1): 325.     CrossRef
  • Disrupted epithelial permeability as a predictor of severe COVID‐19 development
    Duygu Yazici, Eren Cagan, Ge Tan, Manru Li, Evan Do, Ozan C. Kucukkase, Abdurrahman Simsek, Muhammed Ali Kizmaz, Tugce Bozkurt, Tamer Aydin, Anja Heider, Beate Rückert, Marie‐Charlotte Brüggen, Raja Dhir, Liam O'Mahony, Mubeccel Akdis, Kari C. Nadeau, Fer
    Allergy.2023; 78(10): 2644.     CrossRef

JMD : Journal of Movement Disorders Twitter
Close layer
TOP